Ten valent vaccine prevents most invasive pneumococcal diseaseBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7826 (Published 20 November 2012) Cite this as: BMJ 2012;345:e7826
GlaxoSmithKline have confirmed that their 10 valent pneumococcal vaccine prevents invasive disease in vaccinated infants. The vaccine was licensed in 2009, on the basis that it generated a good immune response. A new trial from Finland shows that it also prevents 92-100% of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial